Legend Biotech LEGN
NASDAQ LEGN
$19.32 -0.57 (-2.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021)

Updated

Legend Biotech's Long-Term Deferred Tax came in at $22.8 million for Q4 2021, down 26.0% from $30.8 million a year earlier.

Analysis

Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021) Analysis & Trends

  • Long-Term Deferred Tax carries a three-year compound annual growth rate of -30.8% (FY2018 to FY2021).
  • Going back by year, Long-Term Deferred Tax was $30.8 million in FY2020 (+438.9%), $5.72 million in FY2019 (-91.7%) and $68.92 million in FY2018.
  • The Q4 2021 figure represents the lowest quarterly Long-Term Deferred Tax since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Legend Biotech 3.67 Bn -74.25 Mn 251.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 22.80 Mn
Dec 31, 2020 30.80 Mn
Dec 31, 2019 5.72 Mn
API Access

Legend Biotech Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=LEGN&period=max&api_key=YOUR_API_KEY